Circulating Biomarker for Liquid Biopsy Market Insights Video

According to Cognitive Market Research, the global Circulating Biomarker for Liquid Biopsy market size was USD XX million in 2024. It will expand at a compound annual growth rate (CAGR) of 12.60% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD XX million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.0% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2031.
• The Blood Tests held the highest Circulating Biomarker for Liquid Biopsy market revenue share in 2024.